Investment Comment Inco's recap plans make it a buy

With a resounding 72% of shareholders approving Inco Ltd.'s controversial recapitalization plan, investors continue to support the company's share price around the $39 mark. The recapitalization plan, which is comprised of a poison pill and a $10(US) special dividend, will...

By continuing to browse you agree to our use of cookies. To learn more, click more information

Dear user, please be aware that we use cookies to help users navigate our website content and to help us understand how we can improve the user experience. If you have ideas for how we can improve our services, we’d love to hear from you. Click here to email us. By continuing to browse you agree to our use of cookies. Please see our Privacy & Cookie Usage Policy to learn more.

Close